-
1
المؤلفون: Saskia Middeldorp, Gary E. Raskob, Patrick Mismetti, Martin H. Prins, Dagmar Kubitza, Martin Gebel, Hugo ten Cate, Jeffrey I. Weitz, Jan Beyer-Westendorf, Anthonie W. A. Lensing, Timothey Brighton, Paolo Prandoni
المساهمون: Interne Geneeskunde, RS: CARIM - R1.04 - Clinical thrombosis and haemostasis, MUMC+: MA Alg Interne Geneeskunde (9), RS: CAPHRI - R5 - Optimising Patient Care, Epidemiologie, MUMC+: KIO Kemta (9), ACS - Pulmonary hypertension & thrombosis, Vascular Medicine, Amsterdam Reproduction & Development (AR&D)
المصدر: Thrombosis Research, 170, 75-83. Elsevier Science
Thrombosis research, 170, 75-83. Elsevier Limitedمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Deep vein, Hemorrhage, 030204 cardiovascular system & hematology, Gastroenterology, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Rivaroxaban, Internal medicine, medicine, Humans, 030212 general & internal medicine, DEEP-VEIN THROMBOSIS, Young adult, Aged, Prothrombin time, medicine.diagnostic_test, EINSTEIN-DVT, business.industry, Hematology, Venous Thromboembolism, Middle Aged, medicine.disease, XA INHIBITOR RIVAROXABAN, Thrombosis, Pulmonary embolism, medicine.anatomical_structure, ORAL RIVAROXABAN, Female, business, Venous thromboembolism, Major bleeding, medicine.drug, Factor Xa Inhibitors
-
2
المؤلفون: Paul Monagle, Anthonie W A Lensing, Kirstin Thelen, Ida Martinelli, Christoph Male, Amparo Santamaría, Elena Samochatova, Riten Kumar, Susanne Holzhauer, Paola Saracco, Paolo Simioni, Jeremy Robertson, Gernot Grangl, Jacqueline Halton, Phillip Connor, Guy Young, Angelo C Molinari, Ulrike Nowak-Göttl, Gili Kenet, Stefanie Kapsa, Stefan Willmann, Akos F Pap, Michael Becka, Teresa Twomey, Jan Beyer-Westendorf, Martin H Prins, Dagmar Kubitza, Werner Streif, Jorge Carniero, Sandra Logetto, Leonardo Brandao, Pascal Amedro, Damien Bonnet, Sven Dietrich, Krisztian Kallay, Shoshana Revel-Vilk, Hannah Tamary, Paola Giordano, Maria Abbattista, Andrea Artoni, Daniela Tormene, Hiroshi Ono, Maroeska WM Te Loo, Heleen Van Ommen, Margreet A Veening, Monique H Suiker, Marjolein Peters, Anastasia Shamardina, Nizhny Novgorod, Lyudmila Zubarovskaya, Maria A Dasi, Maria Elorza, Amparo Santamaria, Manuel Sánchez-Luna, Manuela Albisetti, Sebastian Grunt, Kaan Kavakli, Tina Biss, Philip Connor, Mike Williams, Suchitra Acharya, Rumi Bhat, Susan Kearney, Kavita Patel, Madvi Rajpukar, Jeffrey H Schwartz, Terry Vik, Tung Wynn, Donald L Yee
المساهمون: MUMC+: KIO Kemta (9), Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, Pediatric surgery
المصدر: The Lancet Haematology, 6(10), E500-E509. ELSEVIER SCI LTD
Lancet Haematology
r-FISABIO. Repositorio Institucional de Producción Científica
instname
The Lancet Haematology, 6(10), e500-e509. Lancet Publishing Group
Monagle, P, Lensing, A W A, Thelen, K, Martinelli, I, Male, C, Santamaría, A, Samochatova, E, Kumar, R, Holzhauer, S, Saracco, P, Simioni, P, Robertson, J, Grangl, G, Halton, J, Connor, P, Young, G, Molinari, A C, Nowak-Göttl, U, Kenet, G, Kapsa, S, Willmann, S, Pap, A F, Becka, M, Twomey, T, Beyer-Westendorf, J, Prins, M H, Kubitza, D & EINSTEIN-Jr Phase 2 Investigators 2019, ' Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies ', The Lancet Haematology, vol. 6, no. 10, pp. e500-e509 . https://doi.org/10.1016/S2352-3026(19)30161-9مصطلحات موضوعية: Male, Pediatrics, Fondaparinux, 0302 clinical medicine, Rivaroxaban, Drug Dosage Calculations, DEEP-VEIN THROMBOSIS, Young adult, Adolescent, Anemia, Anticoagulants, Body Weight, Child, Child, Preschool, Drug Administration Schedule, Factor Xa, Female, Half-Life, Hemorrhage, Humans, Infant, Neutropenia, Prothrombin Time, Treatment Outcome, Venous Thromboembolism, Hematology, Vitamin K antagonist, REPORTED TREATMENT SATISFACTION, ORAL RIVAROXABAN, 030220 oncology & carcinogenesis, medicine.symptom, medicine.drug, medicine.medical_specialty, medicine.drug_class, Asymptomatic, 03 medical and health sciences, medicine, Dosing, Preschool, business.industry, medicine.disease, XA INHIBITOR RIVAROXABAN, Clinical trial, DEFINITION, ATRIAL-FIBRILLATION, business, STANDARD THERAPY, 030215 immunology
-
3Academic Journal
المؤلفون: ten Cate, Hugo, Lensing, Anthonie W. A., Weitz, Jeffrey I., Middeldorp, Saskia, Beyer-Westendorf, Jan, Kubitza, Dagmar, Brighton, Timothey, Raskob, Gary E., Mismetti, Patrick, Prandoni, Paolo, Gebel, Martin, Prins, Martin H.
المصدر: ten Cate , H , Lensing , A W A , Weitz , J I , Middeldorp , S , Beyer-Westendorf , J , Kubitza , D , Brighton , T , Raskob , G E , Mismetti , P , Prandoni , P , Gebel , M & Prins , M H 2018 , ' The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients ' , Thrombosis Research , vol. 170 , pp. 75-83 . https://doi.org/10.1016/j.thromres.2018.08.008
مصطلحات موضوعية: DEEP-VEIN THROMBOSIS, XA INHIBITOR RIVAROXABAN, ORAL RIVAROXABAN, EINSTEIN-DVT
-
4
المؤلفون: V.E.A. Gerdes, P. S. Wells, H.R. Büller, Peter Verhamme, Pieter Willem Kamphuisen, A. W. A. Lensing, Henri Bounameaux, Renée A. Douma, J. Van Es
المساهمون: Cardiovascular Centre (CVC), Vascular Ageing Programme (VAP), Faculteit Medische Wetenschappen/UMCG, Vascular Medicine, Other departments, ACS - Amsterdam Cardiovascular Sciences
المصدر: Journal of Thrombosis and Haemostasis, 11, 242-242. Wiley
Journal of Thrombosis and Haemostasis, 11(4), 679-685. Wiley
Journal of thrombosis and haemostasis, 11(4), 679-685. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 4 (2013) pp. 679-685
Journal of Thrombosis and Haemostasis, 11. Wileyمصطلحات موضوعية: Male, Clot resolution, pulmonary embolism, perfusion scintigraphy, Scintigraphy, ANGIOGRAPHY, computer assisted tomography, Pulmonary angiography, scintigraphy, DEEP-VEIN THROMBOSIS, rivaroxaban, ddc:616, medicine.diagnostic_test, Blood vessel occlusion, enoxaparin, Hematology, Middle Aged, Thrombosis, obstruction, Pulmonary embolism, clot resolution, antivitamin K, Female, Radiology, patient, history, THROMBOEMBOLI, Perfusion, lung embolism, medicine.drug, safety, Adult, medicine.medical_specialty, Perfusion Imaging, blood vessel occlusion, lung angiography, medicine, Humans, human, Anticoagulant therapy, Perfusion scintigraphy, Aged, Rivaroxaban, anticoagulant therapy, business.industry, Anticoagulants, CT-scan, medicine.disease, XA INHIBITOR RIVAROXABAN, society, Angiography, hemostasis, business, Nuclear medicine, Tomography, X-Ray Computed, FOLLOW-UP